AMICUS THERAPEUTICS, INC. — Director's Dealing 2012

Apr 19, 2012

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2012-04-16

Reporting Person: Baird William D III (Chief Financial Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options (right to buy)	$4.66	2022-04-18	Common Stock (175000)		Direct

Footnotes

F1: These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vest on April 18, 2013. The remaining options vest and become exercisable in a series of thirty-five equal monthly installments, beginning on May 1, 2013, with a final installment vesting on April 18, 2016.